CLGN
Price
$2.85
Change
-$0.03 (-1.04%)
Updated
Aug 8 closing price
Capitalization
36.62M
11 days until earnings call
INTS
Price
$0.27
Change
+$0.02 (+8.00%)
Updated
Aug 8 closing price
Capitalization
12.42M
101 days until earnings call
Interact to see
Advertisement

CLGN vs INTS

Header iconCLGN vs INTS Comparison
Open Charts CLGN vs INTSBanner chart's image
CollPlant Biotechnologies
Price$2.85
Change-$0.03 (-1.04%)
Volume$20.36K
Capitalization36.62M
Intensity Therapeutics
Price$0.27
Change+$0.02 (+8.00%)
Volume$5.46M
Capitalization12.42M
CLGN vs INTS Comparison Chart in %
Loading...
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLGN vs. INTS commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Hold and INTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (CLGN: $2.85 vs. INTS: $0.27)
Brand notoriety: CLGN and INTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 23% vs. INTS: 129%
Market capitalization -- CLGN: $36.62M vs. INTS: $12.42M
CLGN [@Biotechnology] is valued at $36.62M. INTS’s [@Biotechnology] market capitalization is $12.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileINTS’s FA Score has 0 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • INTS’s FA Score: 0 green, 5 red.
According to our system of comparison, CLGN is a better buy in the long-term than INTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLGN’s TA Score shows that 6 TA indicator(s) are bullish while INTS’s TA Score has 4 bullish TA indicator(s).

  • CLGN’s TA Score: 6 bullish, 4 bearish.
  • INTS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CLGN is a better buy in the short-term than INTS.

Price Growth

CLGN (@Biotechnology) experienced а +24.43% price change this week, while INTS (@Biotechnology) price change was +12.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

CLGN is expected to report earnings on Aug 20, 2025.

INTS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLGN($36.6M) has a higher market cap than INTS($12.4M). CLGN YTD gains are higher at: -20.833 vs. INTS (-84.665). CLGN has higher annual earnings (EBITDA): -13.57M vs. INTS (-14.92M). CLGN has more cash in the bank: 10.7M vs. INTS (929K). INTS has less debt than CLGN: INTS (131K) vs CLGN (2.84M). CLGN has higher revenues than INTS: CLGN (2.47M) vs INTS (0).
CLGNINTSCLGN / INTS
Capitalization36.6M12.4M295%
EBITDA-13.57M-14.92M91%
Gain YTD-20.833-84.66525%
P/E RatioN/AN/A-
Revenue2.47M0-
Total Cash10.7M929K1,152%
Total Debt2.84M131K2,170%
FUNDAMENTALS RATINGS
CLGN: Fundamental Ratings
CLGN
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
37

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLGNINTS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 5 days ago
68%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBT23.730.27
+1.15%
Orange County Bancorp Inc
WM235.091.87
+0.80%
Waste Management
FKWL3.76-0.01
-0.37%
Franklin Wireless Corp
SEE29.32-0.22
-0.74%
Sealed Air Corp
HE10.79-0.25
-2.26%
Hawaiian Electric Industries

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with SPRO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
-1.04%
SPRO - CLGN
39%
Loosely correlated
+0.92%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
-2.26%
VOR - CLGN
25%
Poorly correlated
N/A
INTS - CLGN
24%
Poorly correlated
+7.10%
More

INTS and

Correlation & Price change

A.I.dvisor tells us that INTS and ACAD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and ACAD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
+7.10%
ACAD - INTS
28%
Poorly correlated
+0.82%
CCCC - INTS
27%
Poorly correlated
-3.10%
OABI - INTS
25%
Poorly correlated
+4.79%
GPCR - INTS
25%
Poorly correlated
+0.68%
CLGN - INTS
24%
Poorly correlated
-1.04%
More